“…[1,2,7,14,15]. Along with infl ammatory cytokines, activated macrophages produce destructive matrix metalloproteinases (MMP) inducing degradation of extracellular matrix of the plaque cap [2,5,7]. These data were confi rmed by clinical studies detecting high levels of some infl ammatory-destructive biomarkers, in particular IL-6, highly-sensitive C-reactive protein (CRP), MMP-3, and MMP-9, in patients with ACS [3][4][5], therefore they are now considered by many authors as biomarkers of atherosclerotic plaque instability [2][3][4][5]10,11].…”